Trade ZBIO anytime, even after market hours
Regulated by
MAS
Trusted by
400,000+ users
Zenas BioPharma, Inc. (ZBIO) is trading at US$31.54, down 3.33% today as of Aug 28, 13:01 EDT. The company has a market capitalisation of US$2.1B. Over the past 52 weeks, ZBIO has traded between US$13.50 and US$44.60. On Syfe you can trade ZBIO with $0 commission and add it to your watchlist.
| Previous close | US$32.62 |
|---|---|
| Market cap | US$2.1B |
| 52-week range | US$13.50 – US$44.60 |
| Volume | 658.97K |
| Exchange | US |
Add to Watchlist
Set Price Alert
Zenas BioPharma, Inc.
Zenas BioPharma, Inc. is a clinical-stage global biopharmaceutical company, which engages in the development and commercialization of transformative immunology-based therapies for patients. The company was founded by Lonnie O. Moulder Jr on November 12, 2019 and is headquartered in Waltham, MA.
Year: 2024
Zenas BioPharma Bear Case Overlooks Obexelimab's Commercial Potential, Wedbush Says
Jul 17, 12:13 PM · MT Newswires
Exchange-Traded Funds, Equity Futures Mixed Pre-Bell Wednesday Amid Fresh Economic Signals
Jun 3, 1:10 PM · MT Newswires
Zenas BioPharma's Potential Autoimmune Disease Treatment Meets Primary, Secondary Endpoints in Phase 3 Study
Jun 3, 8:41 AM · MT Newswires
Zenas BioPharma, Inc. (ZBIO) stock is trading at US$31.54, -3.33% from the previous close of US$32.62.
The market cap for Zenas BioPharma, Inc. (ZBIO) stock is approximately US$2.1B.
The 52-week high for Zenas BioPharma, Inc. (ZBIO) stock is US$44.60.
The 52-week low for Zenas BioPharma, Inc. (ZBIO) stock is US$13.50.
Zenas BioPharma, Inc. (ZBIO) does not currently pay a dividend.
Stay on top of ZBIO
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
